Results 181 to 190 of about 189,257 (404)
Abstract Background Erectile dysfunction (ED) affects up to 50% of men over 40. While phosphodiesterase‐5 inhibitors (PDE5i) are the first line of medical treatment, they are not always effective. Alprostadil, available in injectable, topical, and intraurethral forms, offers an alternative treatment modality.
Iason Papadopoulos+8 more
wiley +1 more source
Renal Scintigraphy with 197Hg-Chlormerodrin
Katsushi Watanabe+3 more
openalex +2 more sources
Greetings from below the aortic arch! The paradigm of cardiac paraganglioma. [PDF]
Heufelder, Armin E., Hofbauer, Lorenz C.
core +1 more source
Secondary Cardiomyopathy Due to Selenium Deficiency: Multidimensional Cardiac Evaluation and Treatment. [PDF]
Fujita Y+7 more
europepmc +1 more source
Role of gallium 67 thoracic scintigraphy in the diagnosis and staging of patients suspected of bronchial carcinoma. [PDF]
R Pannier+3 more
openalex +1 more source
Objectives To review the clinical utility, outcome and possible future applications of sentinel lymph node biopsy (SLNB) in penile cancer (PeC), bladder cancer (BCa), prostate cancer (PCa), testicular cancer (TCa) and renal cell carcinoma (RCC), focusing in particular on current SLNB standards and exploring advancements in imaging agents, intra ...
Erik J. van Gennep+7 more
wiley +1 more source
Diagnosis of Pancreatic Diseases by Scintigraphy
Masatada TANABE+8 more
openalex +2 more sources
Effect of cold stimulation on myocardial perfusion. An investigation using thallium-201 scintigraphy. [PDF]
J C Rodger+3 more
openalex +1 more source
Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate‐risk prostate cancer
Objective To provide a comprehensive review and analysis of guidelines from various professional and medical organisations regarding the use of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) as a staging scan for men with newly diagnosed intermediate‐risk prostate cancer (PCa).
Jonathon Carll+5 more
wiley +1 more source